Soon, I will be introducing legislation that requires health insurers to cap the cost of Epinephrine Delivery Systems and limits the out-of-pocket cost for consumers to $35. This will make this life-saving treatment more affordable for Pennsylvanians who need it.

The price of epinephrine delivery systems has dramatically increased, far exceeding the rate of inflation. Reports indicate that over the past 11 years, the list price of these delivery systems has skyrocketed by 574%, from $90.28 in 2006 to between $650 and $750 today.

Epinephrine delivery systems have a relatively short shelf life, expiring after an average of 12 months, which means those in need must repeatedly purchase the medication. To add to the expense, users are advised to carry multiple doses, as a single dose of epinephrine may not be sufficient to treat a serious allergic reaction. Because of the rising costs, many individuals who are prescribed these delivery systems attempt to stretch out their supply by using them past their expiration dates or delaying filling their prescriptions.

For those with severe allergies, having immediate access to an epinephrine delivery system can mean the difference between life and death. For parents with children who have severe allergies, a household can spend up to $2,500 a year to ensure they have enough doses on hand. When every second counts, the last thing Pennsylvanians should worry about is whether they can afford the medication they need to survive an anaphylactic reaction.

Please join me in supporting this crucial and life-saving legislation.

Statutes/Laws affected:
Printer's No. 1371 (Dec 29, 2025): P.L.682, No.284